Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

HISTORICAL FACTS: Mdt - The Untold Story

How Is Zimmer Biomet Holdings’ Stock Performance Compared to Other Medical Devices Stocks?

Zimmer Biomet Holdings stock has lagged other medical device stocks over the past year, while analysts are neutral about its prospects.

Barchart

Should You Buy MMED Stock After the MiniMed IPO?

MiniMed, a spinoff of Medtronic, is expected to price its IPO on March 5.

Barchart

These 3 Dividend Aristocrats Look Ready to Rebound in 2026. Should You Buy Them Now?

Three oversold Dividend Aristocrats near recent lows offering reliable income, strong analyst support, and significant upside potential.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Medtronic’s “Textbook” Reversal: How High Can It Really Go in 2026?

Medtronic's stock price reversal gained traction in late fiscal 2025, setting the market up for a 2026 rally, potentially hitting $125.

MarketBeat

Stocks Retreat on AI Anxiety

The S&P 500 Index ($SPX ) (SPY ) today is down -0.27%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.22%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.51%. March E-mini S&P futures (ESH26 ) are down -0.20%, and March E-mini Nasdaq futures...

Barchart

Are Wall Street Analysts Predicting Medtronic Stock Will Climb or Sink?

Although Medtronic has lagged behind the S&P 500 Index over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Barchart

What to Expect From Medtronic's Next Quarterly Earnings Report

Medtronic is expected to announce its fiscal third-quarter earnings next month, and analysts project a single-digit profit drop.

Barchart

Read news from The Economist, FT, and more,
with one subscription

3 Best Dividend Aristocrats to Buy in 2026

These Dividend Aristocrats have strong earnings growth, solid yields, and Wall Street buy ratings stand out as smart income plays for 2026.

Barchart

Medtronic Scores FDA Win As Hugo Surgical Robot Enters 230,000 Urology Procedure Market

On Wednesday, the U.S. Food and Drug Administration (FDA) cleared Medtronic Plc’s (NYSE:MDT) Hugo robotic-assisted surgery (RAS) system for use in urologic surgical procedures.

Benzinga

How Is Medtronic's Stock Performance Compared to Other Medical Devices Stocks?

Medtronic has outperformed the Medical Devices industry over the past year, and analysts are cautiously optimistic about the stock’s prospects.

Barchart

Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum

Medtronic is on track to advance in 2026 and could rise by 20% to 30% before year-end. Analysts and institutions are accumulating in 2025.

MarketBeat

Stock Indexes Slump as the Slide in Tech Stocks Deepens

The S&P 500 Index ($SPX ) (SPY ) today is down by -1.17%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -1.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -1.57%. December E-mini S&P futures (ESZ25 ) are down -1.09%, and December...

Barchart

Stocks Fall on Tech Stock Weakness and Disappointing Home Depot Earnings

The S&P 500 Index ($SPX ) (SPY ) today is down by -0.51%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.86%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.90%. December E-mini S&P futures (ESZ25 ) are down -0.54%, and December...

Barchart

This Medical Device Maker Is Seeing High Demand In Cardiovascular, Diabetes Business

Medtronic Plc (NYSE:MDT) on Tuesday reported strong second-quarter 2026 results, with sales hitting $8.96 billion, surpassing the consensus estimate of $8.87 billion. This marks a 6.6% increase year-over-year, with organic growth of 5.5%.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Is Wall Street Bullish or Bearish on Medtronic Stock?

Despite underperforming the market over the past year, Medtronic still enjoys fairly upbeat outlook from analysts.

Barchart

What to Expect From Medtronic's Q2 2026 Earnings Report

Medtronic is expected to release its second-quarter results next month, and analysts project a single-digit earnings increase.

Benzinga

Medtronic Kicks Off US Study On Robot-Assisted Surgeries For Women

Medtronic plc (NYSE:MDT) Wednesday announced the commencement of the Embrace Gynecology investigational device exemption (IDE) U.S. clinical study to assess the safety and effectiveness of its Hugo robotic-assisted surgery (RAS) system in gynecological procedures.

Benzinga

Medtronic's New Implant Could Transform Bladder Control Treatment

Innovative medical technologies are transforming healthcare by tackling chronic conditions that affect millions, offering hope and improved quality of life. The Food and Drug Administration (FDA) approved Medtronic plc’s (NYSE:MDT) Altaviva device on Friday.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Medtronic's Hugo Robotic System Achieves 100% Success Rate In Hernia Repair Trial

Medtronic PLC (NYSE:MDT) released on Thursday results from the Enable Hernia Repair clinical study evaluating the performance of the Hugo robotic-assisted surgery (RAS) system in inguinal and ventral hernia repair procedures.

Barchart

Medtronic Stock: Is MDT Outperforming the Healthcare Sector?

Medtronic has significantly outperformed the broader healthcare sector over the past year and in recent months, and analysts remain bullish on the stock’s prospects.

Benzinga

Medtronic To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Medtronic Has Potential To Pursue Further Divestitures: Analyst

On Tuesday, Medtronic Plc (NYSE:MDT) reported second-quarter earnings and announced key board appointments after Elliott Investment Management became the company's largest shareholder.

Benzinga

These Analysts Boost Their Forecasts On Medtronic After Upbeat Q1 Earnings

Medtronic plc (NYSE:MDT) posted better-than-expected earnings for the first quarter and announced key board appointments on Tuesday, naming John Groetelaars and Bill Jellison as independent directors, effective immediately.

MarketBeat

Medtronic: The Opportunity Gets Healthier for Income Investors

Medtronic is on track to complete a market reversal in 2025. Sell-siders, including activists, analysts, and institutions, are buying this stock in 2025.

Benzinga

Medtronic Lifts Annual Outlook, Appoints New Directors In Post-Elliott Strategic Shift

Medtronic plc (NYSE:MDT) announced key board appointments on Tuesday, naming John Groetelaars and Bill Jellison as independent directors, effective immediately. This move comes shortly after Elliott Investment Management became the company’s largest shareholder.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Wall Street Journal

Dow Jones Industrials

316 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.